These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25862436)

  • 21. [Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack].
    Masjuán J; Álvarez-Sabín J; Blanco M; de Felipe A; Gil-Núñez A; Gállego-Culleré J; Vivancos J
    Rev Neurol; 2014 Jul; 59(1):25-36. PubMed ID: 24965928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke　- ANAFIE Registry.
    Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
    Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000185. PubMed ID: 10796313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
    Cappellari M; Carletti M; Danese A; Bovi P
    J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.
    Min J; Farooq MU
    Postgrad Med; 2016 Aug; 128(6):620-8. PubMed ID: 27263867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
    Akins PT; Feldman HA; Zoble RG; Newman D; Spitzer SG; Diener HC; Albers GW
    Stroke; 2007 Mar; 38(3):874-80. PubMed ID: 17255547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
    Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
    Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack.
    Saxena R; Koudstaal PJ
    Cochrane Database Syst Rev; 2004; (2):CD000185. PubMed ID: 15106146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of Stroke in Atrial Fibrillation After Coronary Stenting.
    Knijnik L; Rivera M; Blumer V; Cardoso R; Fernandes A; Fernandes G; Ferreira T; Romano JG; Lambrakos LK; Cohen MG
    Stroke; 2019 Aug; 50(8):2125-2132. PubMed ID: 31303150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
    Johnson P; Rosewell M; James MA
    Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis.
    Mosconi MG; Maraziti G; Paciaroni M; Giustozzi M; Vedovati MC; Bogliari G; Urbini C; Traballi L; Caso V
    Eur Neurol; 2023; 86(1):13-24. PubMed ID: 36099877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
    Lasek-Bal A; Urbanek T; Gierek D
    Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.